The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

FGFR3

—Fibroblast Growth Factor Receptor 3

Chromosome: 4

Location: 4:1793286-1808873

OMIM: 134934

Ensembl: ENSG00000068078

Official·OMIM:134934 Official·ENSG00000068078

Encodes fibroblast growth factor receptor. Mutations cause achondroplasia and bladder cancer.

Treatment Roadmap — FGFR3

Preclinical

Phase 1

5 trial

Phase 2

10 trial

Phase 3

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Achondroplasia

Autosomal DominantPrevalence: 1/25000skeletal

Official·OMIM:100800 Official·ORPHA15

Summary

Clinical Trial

Approved Therapy

Registered Variant